U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. California Vaping Company Inc. - 613513 - 06/04/2021
  1. Warning Letters

CLOSEOUT LETTER

California Vaping Company Inc. MARCS-CMS 613513 —

Delivery Method:
VIA Electronic Mail
Reference #:
RW2101513
Product:
Tobacco
Recipient:
Recipient Name
Dakoda Collins
California Vaping Company Inc.

United States

Sales@CaliVapeCo.com
Issuing Office:
Center for Tobacco Products

United States

Dear Dakoda Collins:

The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated March 10, 2021, March 16, 2021, and May 19, 2021, in response to our Warning Letter dated February 26, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://calivapeco.com.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products

VIA Electronic Mail

cc:

GoDaddy.com, LLC
abuse@godaddy.com

Liquid Web, L.L.C
abuse@liquidweb.com

Back to Top